|
Dr. Göringer received his Ph.D. in 1986 in biochemistry from the Free University of Berlin and in 1997 earned his D.Habil. from the University of Munich. He did postdoctoral research in the United States at Brown University and the Seattle Biomedical Research Institute, University of Washington. From 1992 to 1999, he was principal investigator at the Gene Center of the Max Planck Institute for Biochemistry in Munich. He is currently professor in the Department of Microbiology and Genetics at the Technical University of Darmstadt in Germany. This is his second HHMI international research scholar award.
RESEARCH ABSTRACT SUMMARY:
Nucleic acid–based drugs can be developed by a method known as SELEX, which allows small RNAs (so-called aptamers) with desired functions to be identified. Ulrich Göringer is focusing on aptamers that bind to the parasite Trypanosoma brucei. Trypanosomes cause African sleeping sickness, and he is identifying parasite-specific aptamers, which are used to develop novel therapeutics against this disease.
View Research Abstract
Photo: David Rolls
|
